The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat
- PMID: 2052529
- DOI: 10.1023/a:1015857902238
The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat
Abstract
Naproxen and flurbiprofen form complexes with hydroxypropyl-beta-cyclodextrin; with stability constants of 2207 and 12515 M-1, respectively. However, only small fractions of the drug remain complexed when the drug-cyclodextrin complex is added to plasma in vitro. This result can be explained by albumin effectively competing with cyclodextrin for drug binding and by the simultaneous displacement of the drug from cyclodextrins by plasma cholesterol. Naproxen and flurbiprofen were administered intravenously to rats as cyclodextrin complexes. The disposition in the body of naproxen was not significantly altered by the complexation. This indicates that immediately after administration all drug is removed from the cyclodextrin complex. However, the initial distribution of flurbiprofen was changed upon complexation. Drug concentrations in liver, brain, kidney, and spleen were increased, indicating that hydroxypropyl-beta-cyclodextrin may improve the presentation of the flurbiprofen to biomembranes, as compared with plasma proteins. The effect was transient; 60 min after injection the differences in tissue concentration compared with controls were dissipated. Finally, the importance of protein binding in determining the mode of interaction of cyclodextrins on drug disposition is discussed.
Similar articles
-
Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.J Pharm Sci. 1994 Jun;83(6):833-7. doi: 10.1002/jps.2600830615. J Pharm Sci. 1994. PMID: 9120816
-
Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.Biochim Biophys Acta. 1996 Dec 6;1291(3):237-44. doi: 10.1016/s0304-4165(96)00096-7. Biochim Biophys Acta. 1996. PMID: 8980638
-
Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.J Pharm Sci. 1992 Jun;81(6):524-8. doi: 10.1002/jps.2600810610. J Pharm Sci. 1992. PMID: 1522488
-
Cyclodextrin binding constants as a function of pH for compounds with multiple pKa values.Int J Pharm. 2020 Jul 30;585:119493. doi: 10.1016/j.ijpharm.2020.119493. Epub 2020 Jun 2. Int J Pharm. 2020. PMID: 32502687 Review.
-
Enzyme mimics.Ciba Found Symp. 1991;158:115-22; discussion 122-7, 204-12. doi: 10.1002/9780470514085.ch8. Ciba Found Symp. 1991. PMID: 1935417 Review.
Cited by
-
Sevoflurane-Sulfobutylether-β-Cyclodextrin Complex: Preparation, Characterization, Cellular Toxicity, Molecular Modeling and Blood-Brain Barrier Transport Studies.Molecules. 2015 Jun 3;20(6):10264-79. doi: 10.3390/molecules200610264. Molecules. 2015. PMID: 26046323 Free PMC article.
-
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics.Pharmaceutics. 2025 Feb 22;17(3):288. doi: 10.3390/pharmaceutics17030288. Pharmaceutics. 2025. PMID: 40142952 Free PMC article. Review.
-
Cyclodextrins: their future in drug formulation and delivery.Pharm Res. 1997 May;14(5):556-67. doi: 10.1023/a:1012136608249. Pharm Res. 1997. PMID: 9165524 Review.
-
α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies.Int J Nanomedicine. 2012;7:3211-9. doi: 10.2147/IJN.S31373. Epub 2012 Jun 27. Int J Nanomedicine. 2012. PMID: 22811606 Free PMC article.
-
Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice.Br J Cancer. 1998 Nov;78(9):1165-9. doi: 10.1038/bjc.1998.648. Br J Cancer. 1998. PMID: 9820174 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources